Nuveen Asset Management’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-177,852
| Closed | -$612K | – | 3338 |
|
|
2024
Q1 | $612K | Hold |
177,852
| – | – | ﹤0.01% | 2903 |
|
|
2023
Q4 | $438K | Buy |
177,852
+5,987
| +3% | +$14.7K | ﹤0.01% | 3048 |
|
|
2023
Q3 | $292K | Sell |
171,865
-57,480
| -25% | -$97.7K | ﹤0.01% | 2972 |
|
|
2023
Q2 | $688K | Buy |
+229,345
| New | +$688K | ﹤0.01% | 2815 |
|
|
2022
Q2 | – | Sell |
-104,744
| Closed | -$572K | – | 3244 |
|
|
2022
Q1 | $572K | Buy |
104,744
+52,539
| +101% | +$287K | ﹤0.01% | 2975 |
|
|
2021
Q4 | $1.03M | Sell |
52,205
-11,836
| -18% | -$232K | ﹤0.01% | 2853 |
|
|
2021
Q3 | $1.89M | Buy |
64,041
+22,090
| +53% | +$650K | ﹤0.01% | 2695 |
|
|
2021
Q2 | $1.78M | Sell |
41,951
-2,329
| -5% | -$98.7K | ﹤0.01% | 2767 |
|
|
2021
Q1 | $2.25M | Buy |
+44,280
| New | +$2.25M | ﹤0.01% | 2561 |
|